Latest Barr Virus Stories

2014-06-26 23:02:12

Dr. Arash Bereliani, the founder of the IV Therapy Center in Beverly Hills, spoke recently about a new study showing that intravenous vitamin C is useful for patients with Epstein-Barr virus antibodies. Beverly Hills, CA (PRWEB) June 26, 2014 A new study published in the journal Medical Science Monitor has found that patients who have high levels of Epstein-Barr virus (EBV) antibodies can benefit from intravenous vitamin C. The researchers, Nina A. Mikirova and Ronald Hunninghake of...

2010-08-11 07:07:00

SEATTLE, Aug. 11 /PRNewswire/ -- HemaQuest Pharmaceuticals announced today that it has initiated the Company's Phase 2 clinical trial evaluating its proprietary HQK-1004 therapy for the treatment of lymphomas and related cancers associated with Epstein-Barr virus (EBV) infection. These EBV-related cancers have poor prognoses and short patient survival. Currently available cancer therapies are typically much less effective in patients with EBV-related lymphoid malignancies than in patients...

2010-01-14 14:58:11

Scientists of Helmholtz Zentrum Mnchen have elucidated a crucial mechanism in the lytic cycle of Epstein-Barr virus. A team of researchers led by Professor Wolfgang Hammerschmidt identified the function of a protein which plays a critical role in the proliferation of the virus. The Epstein-Barr virus can induce cancer. The findings, published in the current issue of the renowned journal PNAS, represent a major step forward in understanding tumor development. The Epstein-Barr virus (EBV), a...

2009-09-24 11:48:00

NEW YORK, Sept. 24 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue. http://www.reportlinker.com/p0116164/Whos-Doing-What-in-Molecular-Diagnostics---Kalorama-/-Emmes-Survey-of-US-Laboratories.html From Kalorama Information a unique tool for assessing the diagnostic business today. Working in conjunction with premier diagnostic survey database Emmes Group, Kalorama Information presents the summarized results from a recent survey of...

2009-09-21 06:55:00

ROCHESTER, N.Y., Sept. 21 /PRNewswire/ -- According to Dr. Ila R. Singh, an associate professor of pathology at the University of Utah, "for the first time we have analyzed prostate cancer and normal prostate tissue and found cancers are much more likely to have [the XMRV virus] ... It was also more likely to be present in more aggressive tumors," Singh said. "We found it in 20 percent of the least aggressive tumors and over 45 percent of the most aggressive tumors." More and more studies...

2009-03-24 07:00:00

SAN FRANCISCO, March 24 /PRNewswire/ -- Epiphany Biosciences announced today that the company plans on filing an IND with the Food and Drug Administration (FDA) to study the potential impact of using the antiviral medication valomaciclovir (EPB-348) as an adjunctive therapy in the treatment of multiple sclerosis. Valomaciclovir has been shown to possess potent antiviral activity in vitro against a number of herpes-related viruses, including herpes simplex (HSV), Epstein-Barr virus (EBV),...

Latest Barr Virus Reference Libraries

2011-01-05 16:22:07

The Epstein-Barr virus (EBV), or human herpesvirus 4, is part of the herpes family and causes cancer. It is one of the most common viruses in humans and is correlated to the pathogenesis of multiple autoimmune diseases including rheumatoid arthritis, systemic lupus, dermatomyositis, and multiple sclerosis. It can also cause several lymphoproliferative disorders and cancers. Most people gain adaptive immunity after being infected by EBV. In the US half of all five-year-olds and 90-95% of...

More Articles (1 articles) »
Word of the Day
  • Good cheer; viands.
  • To revel; to feast.
The word 'bellycheer' may come from 'belle cheer', "good cheer".